Japanese Pediatric Leukemia/Lymphoma Study Group (JPLSG) ALL-B12: A Multi-Center Phase II/III Study in Children with Newly Diagnosed B-cell Precursor Acute Lymphoblastic Leukemia
Phase 2
- Conditions
- B cell precursor Acute Lymphoblastic Leukemia
- Registration Number
- JPRN-UMIN000009339
- Lead Sponsor
- Japanese Pediatric Leukemia/Lymphoma Study Group (JPLSG)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- All
- Target Recruitment
- 1940
Inclusion Criteria
Not provided
Exclusion Criteria
1) mature B-ALL 2) Ph positive ALL 3) True Mixed Lineage Leukemia 4) CNS hemorrage more than grade 3 of CACAE v4.0 5) uncontrolled infection, including active tuberculosis and positive of HIV antibody. 6) pregnancy or high possibility of pregnancy and giving suck wiman. 7) history of congenital or acquired immunodeficiency. 8) QTfc, corrected by Friderics formula as QTfc = QT/RR*1/3, is more than 0.45 seconds. 9) any inappropriate status judged by physician.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method